top of page
2000-500_02.jpg

CAR-T & CAR-NK Cell Therapy

NEXJENNER SERVICE

CAR-T / CAR-NK Cell Therapy
Biopharmaceutical
CAR-T treatment is
a T cell-based cell therapy that is genetically engineered to specifically target cancer cells after isolating immune cells from the patient’s body.
CAR-NK treatment is
a cell therapy based on NK cells that are genetically engineered to specifically target cancer cells after isolating immune cells from the healthy human body.
Nexjenner Co., Ltd. provides customized services to develop optimal CAR-T / CAR NK treatments targeting various cancers using various biomarkers.
2000-07-14.jpg

Cancer Biomarker Selection

Nexjenner | INNOVATION CLUSTER

Antibody (scFv) Design and Selection

Nexjenner | INNOVATION CLUSTER

CAR vector Design and Production

Nexjenner | INNOVATION CLUSTER

CAR Gene Delivery

Nexjenner | INNOVATION CLUSTER

In Vitro Anti-Cancer Evaluation

Nexjenner | INNOVATION CLUSTER

In Vivo Anti-Cancer Evaluation

Nexjenner | INNOVATION CLUSTER
bottom of page